Activity value 82colombia Buyer,Last transaction date:
2026-04-06Address: brr providencia mz c lt 16
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for jl pharma chemical design s.a.s. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3 transactions, with a transaction quantity of 52.71 and a transaction weight of 52.71.
YearTransactionsQuantityWeight
20258346.12460.32
2026352.7152.71
Bill of lading data
<
1/15
>
Trade date
2026/04/06
B/L No.
92003006844037
Suppliers
symed laboratories ltd.
Buyers
jl pharma chemical design s.a.s.
Product description
DO:12-5930, PEDIDO:235-36206284, DECLARACION 1 DE 1; FACTURA:90015573, FECHA:12-03-2026. VISTO BUENO INVIMA NO.:VINVIMA-26-0037559 DEL 16/03/2026. PRODUCTO:AZUL DE METILENO, ORIGEN:ORGANICO, COMPOSICION:CLORURO DE 3,7-BIS(DIMETILAMINO)FENOTIAZIN-5-IO PENTAHIDRATADO, ASPECTO FISICO:POLVO CRISTALINO DE COLOR AZUL O VERDE OSCURO, TIPO DE EMPAQUE:(1) TAMBOR X 2.000 GRAMOS Y (1) TAMBOR X 600 GRAMOS, USO:MATERIA PRIMA QUE SERA VENDIDA A ADS PHARMA S.A.S., PARA VENTA Y COMERCIALIZACION DE MEDICAMENTO DE USO HUMANO, MARCA:AXPLORA, REFERENCIA:3000009610 (SEGUN FACTURA); CAS NO.:32680-41-4, FARMACOPEA:FARMACOPEA EUROPEA (EUROPEAN PHARMACOPOEIA), CONCENTRACION O PUERAZA:99% (ELPORCENTAJE RESTANTE CORRESPONDE A IMPUREZAS), BATCH NO.:2100008327/2100013058, CANTIDAD:2,6 KILOGRAMOS.
Expand
Trade date
2026/03/24
B/L No.
92003006546558
Suppliers
alven labs s.r.o.
Buyers
jl pharma chemical design s.a.s.
Product description
DO:12-5929, PEDIDO:3641043151, DECLARACION 1 DE 1; FACTURA:2026011, FECHA:17-03-2026. VISTO BUENO DEL FONDO NACIONAL DE ESTUPEFACIENTES NO.:VFNE-26-00832 DEL 13/03/2026 Y VISTO BUENO INVIMA NO.:VINVIMA-26-0037551 DEL 16/03/2026. PRODUCTO:LEVOSIMENDAN API (PHARMA GRADE), NOMBRE COMERCIAL:LEVOSIMENDAN, NO. CAS (NUMERO DE REGISTRO DEL CHEMICAL ABSTRACTS SERVICE):141505-33-1, CALIDAD:INHOUSE USP, ASPECTO FISICO:POLVO CRISTALINO BLANCO, CONCENTRACION:99% (EL PORCENTAJE RESTANTE CORRESPONDE A IMPUREZAS), TIPO DE EMPAQUE:TAMBOR POR 110 GRAMOS, USO:MATERIA PRIMA QUE SERA VENDIDA A ADVENTUM PHARMA S.A.S. PARA FABRICAR MEDICAMENTOS DE USO HUMANO (PRODUCTO:LEVOSIDAX SOLUCIONINYECTABLE 12.5MG/5ML), MARCA:ALVEN LABORATORIES; BATCH NO.:001052024, CANTIDAD:110 GRAMOS.
Expand
Trade date
2025/11/10
B/L No.
91003047605533
Suppliers
kinlam shanghai biotech co ltd
Buyers
jl pharma chemical design s.a.s.
Product description
DO:12-5648, PEDIDO:729-91647334, DECLARACION 1 DE 1; FACTURA:AD20250820, FECHA:20-08-2025. PARA ESTA IMPORTACION NOS ACOGEMOS AL DECRETO NUMERO 4406 DE DICIEMBRE 30 DE 2004 & 0925 DE MAYO 09 DE 2013 DEL MINISTERIO DE COMERCIOINDUSTRIA Y TURISMO. ANEXO 20 DE LA CIRCULAR 77/02 DEL MINISTERIO DE COMERCIO EXTERIOR /// NOS ACOGEMOS AL DECRETO 272 DE 2018. MODIFICADO POR EL DECRETO 1881 DE 2021. NO CONTIENE MATERIAL RADIOACTIVO Y/O NUCLEAR. MERCANCIANUEVA. PRODUCTO:EQUIPO DE CROMATOGRAFIA LIQUIDA DE ALTA EFICIENCIA (HPLC), MARCA:WOOKING, MODELO:NO TIENE, REFERENCIA:HANNON K2025 (SEGUN FACTURA), SERIAL:NO TIENE, USO O DESTINO:INSTRUMENTO DE ANALISIS QUIMICO CUANTITATIVO YCUALITATIVO DE MATERIAS PRIMAS, PRINCIPIO DE FUNCIONAMIENTO:ELECTRONICO, EQUIPO COMPUESTO POR:(1) BOMBA CUATERNARIA/DESGASIFICADOR DE VACIO, REF:C300400005 (C300400002 SEGUN FACTURA), MODELO:K2025P4 (C300400005), S/N:CS3004A30270006, POWER SUPPLY:100 - 240V A.C. 50/60HZ, POWER:60W; (1) MUESTREADOR AUTOMATICO, REF:C300600014 (C300600012 SEGUN FACTUR
Expand
Trade date
2025/06/04
B/L No.
92003004286388
Suppliers
shanghai t y w pharmaceutical co.ltd.
Buyers
jl pharma chemical design s.a.s.
POLs
——
PODs
bogota
Supply area
China
Purchas area
Colombia
Weight
6kg
Amount
55128
Hs code
2934999000
Product tags
nucleic acids
Product description
DO:12-5379, PEDIDO:881642446159, DECLARACION 1 DE 1; FACTURA:SC250305, FECHA:13-05-2025. VISTO BUENO DEL FONDO NACIONAL DE ESTUPEFACIENTES NO.:VFNE-25-01709 DEL 28/05/2025 Y VISTO BUENO INVIMA NO.:VINVIMA-25-0073627 DEL 28/05/2025. PRODUCTO:BROMURO DE ROCURONIO, NOMBRE COMERCIAL:BROMURO DE ROCURONIO, NO. CAS (NUMERO DE REGISTRO DEL CHEMICAL ABSTRACTS SERVICE):119302-91-9, CALIDAD:USP, ASPECTO FISICO:POLVO BLANCO O AMARILLO PALIDO, CONCENTRACION:101.25%, TIPO DE EMPAQUE:BOLSA POR 6 KG, USO:MATERIA PRIMA QUE SERA VENDIDA A ADS PHARMA S.A.S. PARA FABRICAR MEDICAMENTOS DE USO HUMANO, MARCA:NEUTAN (SHANGHAI T&W PHARMACEUTICAL); BATCH NO.:NEU1017-I-2409500T, CANTIDAD:6 KILOGRAMOS
Expand
Trade date
2025/04/01
B/L No.
92003002514784
Suppliers
symed laboratories ltd.
Buyers
jl pharma chemical design s.a.s.
Product description
DO 12-5149 PEDIDO 607-36296956 DECLARACION 1 DE 1 //FACTURA:JRSE/685/24-25, FECHA:16-01-2025. VISTO BUENO INVIMA NO.:VI
Expand
Trade date
2025/01/27
B/L No.
92003000696158
Suppliers
shanghai t y w pharmaceutical co.ltd.
Buyers
jl pharma chemical design s.a.s.
POLs
——
PODs
bogota
Supply area
China
Purchas area
Colombia
Weight
12kg
Amount
72000
Hs code
2934999000
Product tags
nucleic acids
Product description
DO 12-5156 PEDIDO 771589202638 DECLARACION 1 DE 1 FACTURA:SC250111, FECHA:02-01-2025, VISTO BUENO INVIMA NO VINVIMA-2
Expand
Trade date
2024/12/23
B/L No.
92003009567796
Suppliers
shanghai t y w pharmaceutical co.ltd.
Buyers
jl pharma chemical design s.a.s.
POLs
——
PODs
bogota
Supply area
China
Purchas area
Colombia
Weight
100kg
Amount
4340
Hs code
3003901000
Product tags
medicaments
Product description
DO:12-5052, PEDIDO:729-91341121, DECLARACION 1 DE 1; FACTURA:SC241107, FECHA:08-11-2024. VISTO BUENO INVIMA NO.:VINVIMA-24-0162069 DEL 13/12/2024. PRODUCTO:N-ACETILCISTEINA, NOMBRE COMERCIAL:N-ACETILCISTEINA USP, PRINCIOPIO ACTIVO:ACIDO (R)-2-ACETAMIDO-3-SULFANILPROPANOICO, CONCENTRACION:99.5% (EL PORCENTAJE RESTANTE CORRESPONDE A IMPUREZAS), INDICACIONES TERAPEUTICAS:NO APLICA (ES MATERIA PRIMA), FORMA FARMACEUTICA:NO APLICA (ES MATERIA PRIMA),TIPO DE EMPAQUE:TAMBORES X 25 KG C/U, USO:MATERIA PRIMA QUE SERA VENDIDA A ADS PHARMA S.A.S. PARA FABRICAR MEDICAMENTOS DE USO HUMANO, MARCA:T&W; NO. CAS:616-91-1, CALIDAD:USP, ASPECTO FISICO:POLVO CRISTALINO BLANCO; LOT:20241015, 4 TAMBORES, CADA UNO CON 25 KG; CANTIDAD:100 KILOGRAMOS.
Expand
Trade date
2024/03/26
B/L No.
5303626
Suppliers
bharat explosives ltd.
Buyers
jl pharma chemical design s.a.s.
jl pharma chemical design s.a.s. is colombia Buyer,
and primarily engages in the import and export business of products such as nucleic acids,amino-aldehydes,amino-ketones.
According to the 52wmb.com global trade database, as of 2026-04-06, the company has completed 105 international trades,
with its main trading regions covering china,costa rica,other etc.
The core products include HS2934999000,HS2922390000,HS3204120000 etc,
often transported via bogota,port buenaventura etc,
and its main trading partners are shanghai t&w pharmaceutical co.ltd.,bettersyn co.ltd.,shanghai t y w pharmaceutical co.ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on jl pharma chemical design s.a.s. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.